Natco Pharma has eased access to obesity treatment by launching affordable generic semaglutide under SEMANAT™ and SEMAFULL™. Multi-dose vials cost only ₹1,290, slashing the original price by 90%. Starting in April, patients can also use pen devices, making weight management therapy more convenient and accessible for a wider population.